{"id":347556,"date":"2025-08-25T12:28:37","date_gmt":"2025-08-25T12:28:37","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-verona-pharma\/"},"modified":"2025-08-25T12:28:37","modified_gmt":"2025-08-25T12:28:37","slug":"how-to-buy-verona-pharma","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-verona-pharma\/","title":{"rendered":"Verona Pharma plc (VRNA) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Verona Pharma plc (VRNA) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334018,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-347556","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Verona Pharma plc (VRNA) Hisseleri Nas\u0131l Al\u0131n\u0131r - Verona Pharma plc (VRNA) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Verona Pharma plc (VRNA) Hisseleri Nas\u0131l Al\u0131n\u0131r - Verona Pharma plc (VRNA) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Verona Pharma plc (VRNA) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131 \u00f6\u011frenin ve bu umut vadeden biyoteknoloji hissesinde ak\u0131ll\u0131 yat\u0131r\u0131m kararlar\u0131 verin, kapsaml\u0131 analizimizle.","description_source":{"label":"Description","type":"textarea","formatted_value":"Verona Pharma plc (VRNA) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131 \u00f6\u011frenin ve bu umut vadeden biyoteknoloji hissesinde ak\u0131ll\u0131 yat\u0131r\u0131m kararlar\u0131 verin, kapsaml\u0131 analizimizle."},"intro":"Solunum t\u0131bb\u0131nda devrim yaratan bir \u015firkete yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Verona Pharma plc (VRNA), \u015fu anda biyoteknolojideki en heyecan verici f\u0131rsatlardan birini temsil ediyor. \u00c7\u0131\u011f\u0131r a\u00e7an KOAH tedavileri ve ufukta b\u00fcy\u00fck bir sat\u0131n alma anla\u015fmas\u0131 ile bu hisse, \u00f6nemli getiriler i\u00e7in biletiniz olabilir. VRNA'ya yat\u0131r\u0131m yaparken bilmeniz gereken her \u015feyi detayl\u0131ca inceleyelim.","intro_source":{"label":"Intro","type":"text","formatted_value":"Solunum t\u0131bb\u0131nda devrim yaratan bir \u015firkete yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Verona Pharma plc (VRNA), \u015fu anda biyoteknolojideki en heyecan verici f\u0131rsatlardan birini temsil ediyor. \u00c7\u0131\u011f\u0131r a\u00e7an KOAH tedavileri ve ufukta b\u00fcy\u00fck bir sat\u0131n alma anla\u015fmas\u0131 ile bu hisse, \u00f6nemli getiriler i\u00e7in biletiniz olabilir. VRNA'ya yat\u0131r\u0131m yaparken bilmeniz gereken her \u015feyi detayl\u0131ca inceleyelim."},"body_html":"<h2>\ud83d\udcc8 Verona Pharma Hissesi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2> <p>25 A\u011fustos 2025 itibar\u0131yla, Verona Pharma plc (VRNA) NASDAQ'ta <strong>105,28 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor. Takviminize not edin: <strong>3 Kas\u0131m 2025<\/strong> kesinlikle kritik. VRNA'n\u0131n 3. \u00e7eyrek kazan\u00e7 raporunu yay\u0131nlayaca\u011f\u0131 tarih bu ve tarihsel olarak bu raporlar hisseyi dramatik \u015fekilde hareket ettirdi.<\/p> <h3>Kazan\u00e7 Raporlar\u0131 VRNA Hissesini Nas\u0131l Hareket Ettirir<\/h3> <p>Desen a\u00e7\u0131k - olumlu s\u00fcrprizler b\u00fcy\u00fck momentum yarat\u0131yor. VRNA, 2025 1. \u00e7eyrek sonu\u00e7lar\u0131nda toplam net gelirin 76,3 milyon $ oldu\u011funu ve Ohtuvayre\u00ae sat\u0131\u015flar\u0131n\u0131n 71,3 milyon $ ile (\u00e7eyrekten \u00e7eyre\u011fe %95 art\u0131\u015f) oldu\u011funu bildirdi\u011finde, hisse patlay\u0131c\u0131 bir b\u00fcy\u00fcme g\u00f6sterdi (<a href=\"https:\/\/www.veronapharma.com\/investors\/\">Verona Pharma Yat\u0131r\u0131mc\u0131 \u0130li\u015fkileri<\/a>).<\/p> <p>3 Kas\u0131m'daki yakla\u015fan 3. \u00e7eyrek raporu, Merck sat\u0131n alma zaman \u00e7izelgesi ve devam eden re\u00e7ete b\u00fcy\u00fcmesi g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda daha da \u00f6nemli olabilir. 2025 1. \u00e7eyrekte yakla\u015f\u0131k 25.000 re\u00e7ete doldurulmu\u015f ve 4.600'den fazla benzersiz re\u00e7ete yazar\u0131 ile ticari ivme tart\u0131\u015f\u0131lmaz.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu (Mart-A\u011fustos 2025)<\/h2> <p>Verona Pharma hisseleri, biyoteknolojide en dikkat \u00e7ekici performanslardan birini sergileyerek sadece ge\u00e7en y\u0131l i\u00e7inde <strong>%290'dan fazla<\/strong> y\u00fckseldi (<a href=\"https:\/\/marketchameleon.com\/Overview\/VRNA\/Summary\/\">Market Chameleon<\/a>). \u0130\u015fte detaylar:<\/p> <p><strong>Mart 2025<\/strong>: Yakla\u015f\u0131k 40-45 $ (ticari \u00f6ncesi heyecan)<br\/> <strong>May\u0131s 2025<\/strong>: 60-65 $ (1. \u00e7eyrek kazan\u00e7lar\u0131 beklentileri a\u015ft\u0131)<br\/> <strong>Temmuz 2025<\/strong>: 85-90 $ (Merck sat\u0131n alma duyurusu heyecan\u0131)<br\/> <strong>A\u011fustos 2025<\/strong>: 105+ $ (anla\u015fma beklentisi ve g\u00fc\u00e7l\u00fc temeller)<\/p> <p>Bu inan\u0131lmaz y\u00fckseli\u015fin nedeni nedir?<\/p> <ul> <li>Ohtuvayre\u00ae re\u00e7ete b\u00fcy\u00fcmesi t\u00fcm beklentileri a\u015fmas\u0131<\/li> <li>20 y\u0131ldan uzun s\u00fcredir KOAH i\u00e7in ilk yeni inhalasyon mekanizmas\u0131<\/li> <li>Merck'ten 10 milyar $'l\u0131k sat\u0131n alma teklifi, taban de\u011fer yarat\u0131yor<\/li> <\/ul> <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030<\/h2> <p><strong>2025 (Y\u0131l Sonu)<\/strong>: 107-110 $ \u2192 <strong>TUT<\/strong> (sat\u0131n alma fiyat\u0131 dayana\u011f\u0131)<br\/> <strong>2026<\/strong>: 115-125 $ (sat\u0131n alma sonras\u0131 entegrasyon ba\u015far\u0131s\u0131)<br\/> <strong>2028<\/strong>: 140-160 $ (k\u00fcresel pazar penetrasyonunun geni\u015flemesi)<br\/> <strong>2030<\/strong>: 180-220 $ (\u00fcr\u00fcn hatt\u0131 geni\u015flemesi ve yeni endikasyonlar)<\/p> <p>Merck'in hisse ba\u015f\u0131na 107 $ teklif etti\u011fi sat\u0131n alma (<a href=\"https:\/\/www.veronapharma.com\/news\/merck-to-acquire-verona-pharma-expanding-its-portfolio-to-include-ohtuvayre-ensifentrine-a-first-in-class-copd-maintenance-treatment-for-adults-and-expected-to-drive-growth-into-the-next-dec\/\">Resmi Duyuru<\/a>) do\u011fal bir fiyat tavan\u0131 olu\u015fturuyor, ancak \u015firket y\u00fcr\u00fctmeye devam ederse uzun vadeli b\u00fcy\u00fcme potansiyeli \u00f6nemli \u00f6l\u00e7\u00fcde y\u00fcksek kal\u0131yor.<\/p> <h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3> <ul> <li><strong>Reg\u00fclasyon belirsizli\u011fi<\/strong>: Yeni endikasyonlar i\u00e7in FDA onaylar\u0131 her zaman risk ta\u015f\u0131r<\/li> <li><strong>Klinik deneme aksakl\u0131klar\u0131<\/strong>: Faz 2 \u00fcr\u00fcn hatt\u0131 geli\u015ftirmesi engellerle kar\u015f\u0131la\u015fabilir<\/li> <li><strong>Sat\u0131n alma anla\u015fmas\u0131 riski<\/strong>: Olas\u0131 olmamakla birlikte Merck anla\u015fmas\u0131 teorik olarak iptal olabilir<\/li> <li><strong>Y\u00fcksek volatilite<\/strong>: 1,69 beta de\u011feri piyasa hareketlerinin b\u00fcy\u00fct\u00fcld\u00fc\u011f\u00fcn\u00fc g\u00f6sterir<\/li> <\/ul> <h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3> <ul> <li><strong>Merck sat\u0131n almas\u0131<\/strong>: Hisse ba\u015f\u0131na 107 $ teklifi a\u015fa\u011f\u0131 y\u00f6nl\u00fc koruma sa\u011flar<\/li> <li><strong>Gelir patlamas\u0131<\/strong>: 2025 1. \u00e7eyrek sat\u0131\u015flar\u0131 76,3 milyon $ iken 2024'te 36,12 milyon $<\/li> <li><strong>Re\u00e7ete ivmesi<\/strong>: 1. \u00e7eyrekte 25.000+ re\u00e7ete ve %95 \u00e7eyrek b\u00fcy\u00fcme<\/li> <li><strong>Sekt\u00f6r r\u00fczgarlar\u0131<\/strong>: Solunum terapileri pazar\u0131 y\u0131ll\u0131k %14 b\u00fcy\u00fcyor<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ul> <li><strong>Stratejik al\u0131m yap\u0131n<\/strong>: Merck sat\u0131n alma fiyat\u0131 107 $ do\u011fal destek seviyesi olu\u015fturur - bu fiyat\u0131n alt\u0131nda al\u0131m yapmay\u0131 d\u00fc\u015f\u00fcn\u00fcn<\/li> <li><strong>Uyar\u0131lar kurun<\/strong>: 3 Kas\u0131m kazan\u00e7lar\u0131n\u0131 takip edin - olumlu s\u00fcrprizler sat\u0131n alma fiyat\u0131na do\u011fru itebilir<\/li> <li><strong>Ak\u0131ll\u0131ca \u00e7e\u015fitlendirin<\/strong>: Biyoteknoloji volatil bir alan - kaybetmeyi g\u00f6ze alabilece\u011finiz kadar yat\u0131r\u0131m yap\u0131n<\/li> <li><strong>Esprili yakla\u015f\u0131m<\/strong>: \"VRNA ticareti yapmak, KOAH tedavilerini kullanmak gibidir - volatiliteyi kald\u0131rmak i\u00e7in g\u00fc\u00e7l\u00fc akci\u011ferlere ihtiyac\u0131n\u0131z var, ama rahatlama nefes kesici olabilir!\"<\/li> <\/ul> <h2>\u2705 Verona Pharma plc (VRNA) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir ticaret platformu se\u00e7in<\/td><td>NASDAQ listeleri ve rekabet\u00e7i \u00fccretler sunmas\u0131na dikkat edin<\/td><\/tr> <tr><td>2<\/td><td>Hesab\u0131n\u0131z\u0131 a\u00e7\u0131n ve fonlay\u0131n<\/td><td>Risk almaya haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td><\/tr> <tr><td>3<\/td><td>\"VRNA\" aramas\u0131 yap\u0131n<\/td><td>\u015eirket ad\u0131 yerine sembol\u00fc kullan\u0131n<\/td><\/tr> <tr><td>4<\/td><td>Emir t\u00fcr\u00fcn\u00fc se\u00e7in<\/td><td>Limit emirleri giri\u015f fiyat\u0131n\u0131z\u0131 kontrol etmenize yard\u0131mc\u0131 olur<\/td><\/tr> <tr><td>5<\/td><td>\u0130\u015fleminizi ger\u00e7ekle\u015ftirin<\/td><td>Son onaydan \u00f6nce detaylar\u0131 kontrol edin<\/td><\/tr> <tr><td>6<\/td><td>Pozisyonunuzu izleyin<\/td><td>\u00d6nemli seviyeler i\u00e7in fiyat uyar\u0131lar\u0131 kurun<\/td><\/tr> <tr><td>7<\/td><td>Dolar maliyet ortalamas\u0131 yapmay\u0131 d\u00fc\u015f\u00fcn\u00fcn<\/td><td>Zamanlama riskini azaltmak i\u00e7in al\u0131mlar\u0131 yayg\u0131nla\u015ft\u0131r\u0131n<\/td><\/tr> <tr><td>8<\/td><td>D\u00fczenli olarak g\u00f6zden ge\u00e7irin<\/td><td>Biyoteknoloji aktif takip gerektirir<\/td><\/tr> <tr><td>9<\/td><td>\u00c7\u0131k\u0131\u015f stratejiniz olsun<\/td><td>K\u00e2r alaca\u011f\u0131n\u0131z veya zarar kesece\u011finiz zaman\u0131 bilin<\/td><\/tr> <tr><td>10<\/td><td>Bilgilenmeye devam edin<\/td><td>\u015eirket haberlerini ve sekt\u00f6r trendlerini takip edin<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Neden Uygun?<\/h2> <p>Pocket Option, hisse senedi yat\u0131r\u0131m\u0131n\u0131 herkes i\u00e7in eri\u015filebilir k\u0131lar:<\/p> <ul> <li><strong>Minimum depozito sadece 5 $<\/strong> - stratejileri d\u00fc\u015f\u00fck riskle test etmek i\u00e7in ideal<\/li> <li><strong>Y\u0131ld\u0131r\u0131m h\u0131z\u0131nda do\u011frulama<\/strong> - herhangi bir kimlik belgesi ile dakikalar i\u00e7inde i\u015flem yapmaya ba\u015flay\u0131n<\/li> <li><strong>100'den fazla para \u00e7ekme y\u00f6ntemi<\/strong> - kripto, e-c\u00fczdan ve geleneksel se\u00e7eneklerde esneklik<\/li> <li><strong>Kullan\u0131c\u0131 dostu platform<\/strong> - yeni ba\u015flayanlar i\u00e7in tasarlanm\u0131\u015f sezgisel aray\u00fcz<\/li> <li><strong>E\u011fitim kaynaklar\u0131<\/strong> - kapsaml\u0131 ticaret materyalleri ile \u00f6\u011frenirken kazan\u0131n<\/li> <\/ul> <h2>\ud83c\udf0d 2025'te Verona Pharma: Solunumda Yenilik Lideri<\/h2> <p>Verona Pharma, Ohtuvayre\u00ae ile yenilik\u00e7i solunum terapileri alan\u0131nda liderdir; bu, KOAH bak\u0131m\u0131nda yirmi y\u0131ldan uzun s\u00fcredir onaylanan ilk yeni inhalasyon mekanizmas\u0131d\u0131r. \u015eirketin \u00e7\u0131\u011f\u0131r a\u00e7an \u00e7ift PDE3 ve PDE4 inhibit\u00f6r teknolojisi solunum bak\u0131m\u0131nda paradigma de\u011fi\u015fikli\u011fi yaratmaktad\u0131r.<\/p> <p><strong>2025 e\u011flenceli bilgi<\/strong>: \u0130la\u00e7 devi Merck taraf\u0131ndan sat\u0131n al\u0131nmas\u0131na ra\u011fmen, Verona Pharma ara\u015ft\u0131rma ekibi Amerikan Torasik Derne\u011fi Konferans\u0131'nda yedi yeni analiz sundu ve sat\u0131n alma g\u00f6r\u00fc\u015fmeleri s\u0131ras\u0131nda bile bilimsel liderliklerini s\u00fcrd\u00fcrd\u00fc. Yenili\u011fe ba\u011fl\u0131l\u0131klar\u0131 t\u00fcm s\u00fcre\u00e7 boyunca sars\u0131lmad\u0131!<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Verona Pharma Hissesi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2>\n<p>25 A\u011fustos 2025 itibar\u0131yla, Verona Pharma plc (VRNA) NASDAQ&#8217;ta <strong>105,28 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor. Takviminize not edin: <strong>3 Kas\u0131m 2025<\/strong> kesinlikle kritik. VRNA&#8217;n\u0131n 3. \u00e7eyrek kazan\u00e7 raporunu yay\u0131nlayaca\u011f\u0131 tarih bu ve tarihsel olarak bu raporlar hisseyi dramatik \u015fekilde hareket ettirdi.<\/p>\n<h3>Kazan\u00e7 Raporlar\u0131 VRNA Hissesini Nas\u0131l Hareket Ettirir<\/h3>\n<p>Desen a\u00e7\u0131k &#8211; olumlu s\u00fcrprizler b\u00fcy\u00fck momentum yarat\u0131yor. VRNA, 2025 1. \u00e7eyrek sonu\u00e7lar\u0131nda toplam net gelirin 76,3 milyon $ oldu\u011funu ve Ohtuvayre\u00ae sat\u0131\u015flar\u0131n\u0131n 71,3 milyon $ ile (\u00e7eyrekten \u00e7eyre\u011fe %95 art\u0131\u015f) oldu\u011funu bildirdi\u011finde, hisse patlay\u0131c\u0131 bir b\u00fcy\u00fcme g\u00f6sterdi (<a href=\"https:\/\/www.veronapharma.com\/investors\/\">Verona Pharma Yat\u0131r\u0131mc\u0131 \u0130li\u015fkileri<\/a>).<\/p>\n<p>3 Kas\u0131m&#8217;daki yakla\u015fan 3. \u00e7eyrek raporu, Merck sat\u0131n alma zaman \u00e7izelgesi ve devam eden re\u00e7ete b\u00fcy\u00fcmesi g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda daha da \u00f6nemli olabilir. 2025 1. \u00e7eyrekte yakla\u015f\u0131k 25.000 re\u00e7ete doldurulmu\u015f ve 4.600&#8217;den fazla benzersiz re\u00e7ete yazar\u0131 ile ticari ivme tart\u0131\u015f\u0131lmaz.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu (Mart-A\u011fustos 2025)<\/h2>\n<p>Verona Pharma hisseleri, biyoteknolojide en dikkat \u00e7ekici performanslardan birini sergileyerek sadece ge\u00e7en y\u0131l i\u00e7inde <strong>%290&#8217;dan fazla<\/strong> y\u00fckseldi (<a href=\"https:\/\/marketchameleon.com\/Overview\/VRNA\/Summary\/\">Market Chameleon<\/a>). \u0130\u015fte detaylar:<\/p>\n<p><strong>Mart 2025<\/strong>: Yakla\u015f\u0131k 40-45 $ (ticari \u00f6ncesi heyecan)<br \/> <strong>May\u0131s 2025<\/strong>: 60-65 $ (1. \u00e7eyrek kazan\u00e7lar\u0131 beklentileri a\u015ft\u0131)<br \/> <strong>Temmuz 2025<\/strong>: 85-90 $ (Merck sat\u0131n alma duyurusu heyecan\u0131)<br \/> <strong>A\u011fustos 2025<\/strong>: 105+ $ (anla\u015fma beklentisi ve g\u00fc\u00e7l\u00fc temeller)<\/p>\n<p>Bu inan\u0131lmaz y\u00fckseli\u015fin nedeni nedir?<\/p>\n<ul>\n<li>Ohtuvayre\u00ae re\u00e7ete b\u00fcy\u00fcmesi t\u00fcm beklentileri a\u015fmas\u0131<\/li>\n<li>20 y\u0131ldan uzun s\u00fcredir KOAH i\u00e7in ilk yeni inhalasyon mekanizmas\u0131<\/li>\n<li>Merck&#8217;ten 10 milyar $&#8217;l\u0131k sat\u0131n alma teklifi, taban de\u011fer yarat\u0131yor<\/li>\n<\/ul>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030<\/h2>\n<p><strong>2025 (Y\u0131l Sonu)<\/strong>: 107-110 $ \u2192 <strong>TUT<\/strong> (sat\u0131n alma fiyat\u0131 dayana\u011f\u0131)<br \/> <strong>2026<\/strong>: 115-125 $ (sat\u0131n alma sonras\u0131 entegrasyon ba\u015far\u0131s\u0131)<br \/> <strong>2028<\/strong>: 140-160 $ (k\u00fcresel pazar penetrasyonunun geni\u015flemesi)<br \/> <strong>2030<\/strong>: 180-220 $ (\u00fcr\u00fcn hatt\u0131 geni\u015flemesi ve yeni endikasyonlar)<\/p>\n<p>Merck&#8217;in hisse ba\u015f\u0131na 107 $ teklif etti\u011fi sat\u0131n alma (<a href=\"https:\/\/www.veronapharma.com\/news\/merck-to-acquire-verona-pharma-expanding-its-portfolio-to-include-ohtuvayre-ensifentrine-a-first-in-class-copd-maintenance-treatment-for-adults-and-expected-to-drive-growth-into-the-next-dec\/\">Resmi Duyuru<\/a>) do\u011fal bir fiyat tavan\u0131 olu\u015fturuyor, ancak \u015firket y\u00fcr\u00fctmeye devam ederse uzun vadeli b\u00fcy\u00fcme potansiyeli \u00f6nemli \u00f6l\u00e7\u00fcde y\u00fcksek kal\u0131yor.<\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3>\n<ul>\n<li><strong>Reg\u00fclasyon belirsizli\u011fi<\/strong>: Yeni endikasyonlar i\u00e7in FDA onaylar\u0131 her zaman risk ta\u015f\u0131r<\/li>\n<li><strong>Klinik deneme aksakl\u0131klar\u0131<\/strong>: Faz 2 \u00fcr\u00fcn hatt\u0131 geli\u015ftirmesi engellerle kar\u015f\u0131la\u015fabilir<\/li>\n<li><strong>Sat\u0131n alma anla\u015fmas\u0131 riski<\/strong>: Olas\u0131 olmamakla birlikte Merck anla\u015fmas\u0131 teorik olarak iptal olabilir<\/li>\n<li><strong>Y\u00fcksek volatilite<\/strong>: 1,69 beta de\u011feri piyasa hareketlerinin b\u00fcy\u00fct\u00fcld\u00fc\u011f\u00fcn\u00fc g\u00f6sterir<\/li>\n<\/ul>\n<h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3>\n<ul>\n<li><strong>Merck sat\u0131n almas\u0131<\/strong>: Hisse ba\u015f\u0131na 107 $ teklifi a\u015fa\u011f\u0131 y\u00f6nl\u00fc koruma sa\u011flar<\/li>\n<li><strong>Gelir patlamas\u0131<\/strong>: 2025 1. \u00e7eyrek sat\u0131\u015flar\u0131 76,3 milyon $ iken 2024&#8217;te 36,12 milyon $<\/li>\n<li><strong>Re\u00e7ete ivmesi<\/strong>: 1. \u00e7eyrekte 25.000+ re\u00e7ete ve %95 \u00e7eyrek b\u00fcy\u00fcme<\/li>\n<li><strong>Sekt\u00f6r r\u00fczgarlar\u0131<\/strong>: Solunum terapileri pazar\u0131 y\u0131ll\u0131k %14 b\u00fcy\u00fcyor<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ul>\n<li><strong>Stratejik al\u0131m yap\u0131n<\/strong>: Merck sat\u0131n alma fiyat\u0131 107 $ do\u011fal destek seviyesi olu\u015fturur &#8211; bu fiyat\u0131n alt\u0131nda al\u0131m yapmay\u0131 d\u00fc\u015f\u00fcn\u00fcn<\/li>\n<li><strong>Uyar\u0131lar kurun<\/strong>: 3 Kas\u0131m kazan\u00e7lar\u0131n\u0131 takip edin &#8211; olumlu s\u00fcrprizler sat\u0131n alma fiyat\u0131na do\u011fru itebilir<\/li>\n<li><strong>Ak\u0131ll\u0131ca \u00e7e\u015fitlendirin<\/strong>: Biyoteknoloji volatil bir alan &#8211; kaybetmeyi g\u00f6ze alabilece\u011finiz kadar yat\u0131r\u0131m yap\u0131n<\/li>\n<li><strong>Esprili yakla\u015f\u0131m<\/strong>: &#8220;VRNA ticareti yapmak, KOAH tedavilerini kullanmak gibidir &#8211; volatiliteyi kald\u0131rmak i\u00e7in g\u00fc\u00e7l\u00fc akci\u011ferlere ihtiyac\u0131n\u0131z var, ama rahatlama nefes kesici olabilir!&#8221;<\/li>\n<\/ul>\n<h2>\u2705 Verona Pharma plc (VRNA) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir ticaret platformu se\u00e7in<\/td>\n<td>NASDAQ listeleri ve rekabet\u00e7i \u00fccretler sunmas\u0131na dikkat edin<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesab\u0131n\u0131z\u0131 a\u00e7\u0131n ve fonlay\u0131n<\/td>\n<td>Risk almaya haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>&#8220;VRNA&#8221; aramas\u0131 yap\u0131n<\/td>\n<td>\u015eirket ad\u0131 yerine sembol\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Emir t\u00fcr\u00fcn\u00fc se\u00e7in<\/td>\n<td>Limit emirleri giri\u015f fiyat\u0131n\u0131z\u0131 kontrol etmenize yard\u0131mc\u0131 olur<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>\u0130\u015fleminizi ger\u00e7ekle\u015ftirin<\/td>\n<td>Son onaydan \u00f6nce detaylar\u0131 kontrol edin<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Pozisyonunuzu izleyin<\/td>\n<td>\u00d6nemli seviyeler i\u00e7in fiyat uyar\u0131lar\u0131 kurun<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Dolar maliyet ortalamas\u0131 yapmay\u0131 d\u00fc\u015f\u00fcn\u00fcn<\/td>\n<td>Zamanlama riskini azaltmak i\u00e7in al\u0131mlar\u0131 yayg\u0131nla\u015ft\u0131r\u0131n<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>D\u00fczenli olarak g\u00f6zden ge\u00e7irin<\/td>\n<td>Biyoteknoloji aktif takip gerektirir<\/td>\n<\/tr>\n<tr>\n<td>9<\/td>\n<td>\u00c7\u0131k\u0131\u015f stratejiniz olsun<\/td>\n<td>K\u00e2r alaca\u011f\u0131n\u0131z veya zarar kesece\u011finiz zaman\u0131 bilin<\/td>\n<\/tr>\n<tr>\n<td>10<\/td>\n<td>Bilgilenmeye devam edin<\/td>\n<td>\u015eirket haberlerini ve sekt\u00f6r trendlerini takip edin<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Neden Uygun?<\/h2>\n<p>Pocket Option, hisse senedi yat\u0131r\u0131m\u0131n\u0131 herkes i\u00e7in eri\u015filebilir k\u0131lar:<\/p>\n<ul>\n<li><strong>Minimum depozito sadece 5 $<\/strong> &#8211; stratejileri d\u00fc\u015f\u00fck riskle test etmek i\u00e7in ideal<\/li>\n<li><strong>Y\u0131ld\u0131r\u0131m h\u0131z\u0131nda do\u011frulama<\/strong> &#8211; herhangi bir kimlik belgesi ile dakikalar i\u00e7inde i\u015flem yapmaya ba\u015flay\u0131n<\/li>\n<li><strong>100&#8217;den fazla para \u00e7ekme y\u00f6ntemi<\/strong> &#8211; kripto, e-c\u00fczdan ve geleneksel se\u00e7eneklerde esneklik<\/li>\n<li><strong>Kullan\u0131c\u0131 dostu platform<\/strong> &#8211; yeni ba\u015flayanlar i\u00e7in tasarlanm\u0131\u015f sezgisel aray\u00fcz<\/li>\n<li><strong>E\u011fitim kaynaklar\u0131<\/strong> &#8211; kapsaml\u0131 ticaret materyalleri ile \u00f6\u011frenirken kazan\u0131n<\/li>\n<\/ul>\n<h2>\ud83c\udf0d 2025&#8217;te Verona Pharma: Solunumda Yenilik Lideri<\/h2>\n<p>Verona Pharma, Ohtuvayre\u00ae ile yenilik\u00e7i solunum terapileri alan\u0131nda liderdir; bu, KOAH bak\u0131m\u0131nda yirmi y\u0131ldan uzun s\u00fcredir onaylanan ilk yeni inhalasyon mekanizmas\u0131d\u0131r. \u015eirketin \u00e7\u0131\u011f\u0131r a\u00e7an \u00e7ift PDE3 ve PDE4 inhibit\u00f6r teknolojisi solunum bak\u0131m\u0131nda paradigma de\u011fi\u015fikli\u011fi yaratmaktad\u0131r.<\/p>\n<p><strong>2025 e\u011flenceli bilgi<\/strong>: \u0130la\u00e7 devi Merck taraf\u0131ndan sat\u0131n al\u0131nmas\u0131na ra\u011fmen, Verona Pharma ara\u015ft\u0131rma ekibi Amerikan Torasik Derne\u011fi Konferans\u0131&#8217;nda yedi yeni analiz sundu ve sat\u0131n alma g\u00f6r\u00fc\u015fmeleri s\u0131ras\u0131nda bile bilimsel liderliklerini s\u00fcrd\u00fcrd\u00fc. Yenili\u011fe ba\u011fl\u0131l\u0131klar\u0131 t\u00fcm s\u00fcre\u00e7 boyunca sars\u0131lmad\u0131!<\/p>\n"},"faq":[{"question":"Verona Pharma hisseleri nereden al\u0131nabilir?","answer":"Verona Pharma hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6rmektedir ve bir\u00e7ok \u00e7evrimi\u00e7i arac\u0131 kurum ve ticaret platformu \u00fczerinden sat\u0131n al\u0131nabilir."},{"question":"Merck'in Verona Pharma'y\u0131 sat\u0131n almas\u0131 ne anlama geliyor?","answer":"Merck'in Verona Pharma'y\u0131 sat\u0131n almas\u0131, \u015firketin de\u011ferini art\u0131ran ve hisse fiyat\u0131na destek sa\u011flayan stratejik bir anla\u015fmad\u0131r. Bu, yat\u0131r\u0131mc\u0131lar i\u00e7in potansiyel bir g\u00fcvence ve b\u00fcy\u00fcme f\u0131rsat\u0131 sunar."},{"question":"VRNA hissesinde yat\u0131r\u0131m yaparken hangi riskler vard\u0131r?","answer":"Reg\u00fclasyon belirsizli\u011fi, klinik deneme gecikmeleri, sat\u0131n alma anla\u015fmas\u0131n\u0131n iptal riski ve y\u00fcksek piyasa volatilitesi ba\u015fl\u0131ca riskler aras\u0131ndad\u0131r."},{"question":"Verona Pharma'n\u0131n Ohtuvayre\u00ae \u00fcr\u00fcn\u00fc neden \u00f6nemlidir?","answer":"Ohtuvayre\u00ae, KOAH i\u00e7in yirmi y\u0131ldan uzun s\u00fcredir onaylanan ilk yeni inhalasyon mekanizmas\u0131d\u0131r ve \u015firketin b\u00fcy\u00fcmesinde kritik bir rol oynar."},{"question":"Yeni ba\u015flayan biri VRNA hissesi al\u0131rken nelere dikkat etmeli?","answer":"Stratejik al\u0131m yapmal\u0131, \u00f6nemli kazan\u00e7 raporlar\u0131n\u0131 takip etmeli, yat\u0131r\u0131m\u0131 \u00e7e\u015fitlendirmeli ve sadece kaybetmeyi g\u00f6ze alabilece\u011fi miktarda yat\u0131r\u0131m yapmal\u0131d\u0131r."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Verona Pharma hisseleri nereden al\u0131nabilir?","answer":"Verona Pharma hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6rmektedir ve bir\u00e7ok \u00e7evrimi\u00e7i arac\u0131 kurum ve ticaret platformu \u00fczerinden sat\u0131n al\u0131nabilir."},{"question":"Merck'in Verona Pharma'y\u0131 sat\u0131n almas\u0131 ne anlama geliyor?","answer":"Merck'in Verona Pharma'y\u0131 sat\u0131n almas\u0131, \u015firketin de\u011ferini art\u0131ran ve hisse fiyat\u0131na destek sa\u011flayan stratejik bir anla\u015fmad\u0131r. Bu, yat\u0131r\u0131mc\u0131lar i\u00e7in potansiyel bir g\u00fcvence ve b\u00fcy\u00fcme f\u0131rsat\u0131 sunar."},{"question":"VRNA hissesinde yat\u0131r\u0131m yaparken hangi riskler vard\u0131r?","answer":"Reg\u00fclasyon belirsizli\u011fi, klinik deneme gecikmeleri, sat\u0131n alma anla\u015fmas\u0131n\u0131n iptal riski ve y\u00fcksek piyasa volatilitesi ba\u015fl\u0131ca riskler aras\u0131ndad\u0131r."},{"question":"Verona Pharma'n\u0131n Ohtuvayre\u00ae \u00fcr\u00fcn\u00fc neden \u00f6nemlidir?","answer":"Ohtuvayre\u00ae, KOAH i\u00e7in yirmi y\u0131ldan uzun s\u00fcredir onaylanan ilk yeni inhalasyon mekanizmas\u0131d\u0131r ve \u015firketin b\u00fcy\u00fcmesinde kritik bir rol oynar."},{"question":"Yeni ba\u015flayan biri VRNA hissesi al\u0131rken nelere dikkat etmeli?","answer":"Stratejik al\u0131m yapmal\u0131, \u00f6nemli kazan\u00e7 raporlar\u0131n\u0131 takip etmeli, yat\u0131r\u0131m\u0131 \u00e7e\u015fitlendirmeli ve sadece kaybetmeyi g\u00f6ze alabilece\u011fi miktarda yat\u0131r\u0131m yapmal\u0131d\u0131r."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Verona Pharma plc (VRNA) Hisseleri Nas\u0131l Al\u0131n\u0131r - Verona Pharma plc (VRNA) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-verona-pharma\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Verona Pharma plc (VRNA) Hisseleri Nas\u0131l Al\u0131n\u0131r - Verona Pharma plc (VRNA) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-verona-pharma\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-25T12:28:37+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-verona-pharma\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-verona-pharma\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Verona Pharma plc (VRNA) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Verona Pharma plc (VRNA) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-25T12:28:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-verona-pharma\/\"},\"wordCount\":21,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-verona-pharma\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-verona-pharma\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-verona-pharma\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-verona-pharma\/\",\"name\":\"Verona Pharma plc (VRNA) Hisseleri Nas\u0131l Al\u0131n\u0131r - Verona Pharma plc (VRNA) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-verona-pharma\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-verona-pharma\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp\",\"datePublished\":\"2025-08-25T12:28:37+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-verona-pharma\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-verona-pharma\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-verona-pharma\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-verona-pharma\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Verona Pharma plc (VRNA) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Verona Pharma plc (VRNA) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Verona Pharma plc (VRNA) Hisseleri Nas\u0131l Al\u0131n\u0131r - Verona Pharma plc (VRNA) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-verona-pharma\/","og_locale":"tr_TR","og_type":"article","og_title":"Verona Pharma plc (VRNA) Hisseleri Nas\u0131l Al\u0131n\u0131r - Verona Pharma plc (VRNA) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-verona-pharma\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-25T12:28:37+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-verona-pharma\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-verona-pharma\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Verona Pharma plc (VRNA) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Verona Pharma plc (VRNA) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-25T12:28:37+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-verona-pharma\/"},"wordCount":21,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-verona-pharma\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-verona-pharma\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-verona-pharma\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-verona-pharma\/","name":"Verona Pharma plc (VRNA) Hisseleri Nas\u0131l Al\u0131n\u0131r - Verona Pharma plc (VRNA) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-verona-pharma\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-verona-pharma\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp","datePublished":"2025-08-25T12:28:37+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-verona-pharma\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-verona-pharma\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-verona-pharma\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-verona-pharma\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Verona Pharma plc (VRNA) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Verona Pharma plc (VRNA) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":347562,"slug":"how-to-buy-verona-pharma","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Verona Pharma plc (VRNA) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Verona Pharma plc (VRNA)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-verona-pharma\/"},"pt_AA":{"locale":"pt_AA","id":347560,"slug":"how-to-buy-verona-pharma","post_title":"Como comprar a\u00e7\u00f5es da Verona Pharma plc (VRNA) - Investimento em a\u00e7\u00f5es da Verona Pharma plc (VRNA)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-verona-pharma\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/347556","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=347556"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/347556\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334018"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=347556"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=347556"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=347556"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}